Krankenhaus der Elisabethinen Linz GmbH

Linz 4020

0 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia, Carcinoma, Hepatocellular, Chronic Hepatitis C Infection, Colitis, Ulcerative, Diffuse Large B-cell Lymphoma, Hepatitis C, Chronic

Studies at this site

• Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Running, not enrolling
• An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia — Stopped early
• Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma — Completed
• Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients — Completed
• A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed
• A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed